- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
GU Cancers Symposium 2012 - Empiric antibiotics for an elevated PSA: A randomized, prospective multiinstitutional trial - Session Highlights
February 7, 2012
FDA approves Bayer radium-223 chloride expanded access program
February 7, 2012
Study shows an investigational urine test can predict high-risk prostate cancer in men who choose ‘watchful waiting’
February 7, 2012
Common genetic variants in prostate cancer risk prediction - results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) - Abstract
February 6, 2012
When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer? - Abstract
February 6, 2012
Quality of life associated with treatment of castration-resistant prostate cancer: A review of the literature - Abstract
February 6, 2012
Chemoprevention of prostate cancer: An updated view - Abstract
February 6, 2012
Testosterone and prostate - Abstract
February 6, 2012
Use of androgen deprivation therapy in prostate cancer: Indications and prevalence - Abstract
February 6, 2012
Hematological changes during androgen deprivation therapy - Abstract
February 6, 2012
Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis - Abstract
February 6, 2012
Double-targeted and double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for prostate cancer - Abstract
February 6, 2012
The Epigenetic promise for prostate cancer diagnosis - Abstract
February 6, 2012